Neurorestoration Induced by Mesenchymal Stem Cells: Potential Therapeutic Mechanisms for Clinical Trials

키워드

참고문헌 (89)

1. Gogel S, "Progress and prospects: stem cells and neurological diseases", Gene Ther, 18, pp.1~6 (2011)
2. Lovell-Badge R, "The regulation of human embryo and stem-cell research in the United Kingdom", Nat Rev Mol Cell Biol, 9, pp.998~1003 (2008)
3. Mathews DJ, "Cell-based interventions for neurologic conditions: ethical challenges for early human trials", Neurology, 71, pp.288~293 (2008)
4. Uccelli A, "Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases", Lancet Neurol, 10, pp.649~656 (2011)
5. Martino G, "The therapeutic potential of neural stem cells", Nat Rev Neurosci, 7, pp.395~406 (2006)
6. Erices AA, "Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion", Cell Transplant, 12, pp.555~561 (2003)
7. De Bari C, "Multipotent mesenchymal stem cells from adult human synovial membrane", Arthritis Rheum, 44, pp.1928~1942 (2001)
8. Fukumoto T, "Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro", Osteoarthritis Cartilage, 11, pp.55~64 (2003)
9. Villaron EM, "Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation", Haematologica, 89, pp.1421~1427 (2004)
10. Zuk PA, "Multilineage cells from human adipose tissue: implications for cell-based therapies", Tissue Eng, 7, pp.211~228 (2001)
11. Cao B, "Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential", Nat Cell Biol, 5, pp.640~646 (2003)
12. Parolini O, "Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells", Stem Cells, 26, pp.300~311 (2008)
13. Sekiya I, "Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality", Stem Cells, 20, pp.230~241 (2002)
14. Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)
15. Phinney DG, "Concise review: mesenchymal stem", multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views, 2007, pp.25, 2896~2902
16. 이명우, "Isolation of mesenchymal stem cells from cryopreserved human umbilical cord blood", INTERNATIONAL JOURNAL OF HEMATOLOGY, 81, pp.126~130, SPRINGER TOKYO
17. Kotobuki N, "Cultured autologous human cells for hard tissue regeneration: preparation and characterization of mesenchymal stem cells from bone marrow", Artif Organs, 28, pp.33~39 (2004)
18. Dazzi F, "The role of mesenchymal stem cells in haemopoiesis", Blood Rev, 20, pp.161~171 (2006)
19. Rasmusson I, "Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells", Transplantation, 76, pp.1208~1213 (2003)
20. DelaRosa O, "Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential", Mediators Inflamm, 2010, pp.865601~ (2010)
21. Le Blanc K, "HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells", Exp Hematol, 31, pp.890~896 (2003)
22. Caplan AI, "Mesenchymal stem cells as trophic mediators", J Cell Biochem, 98, pp.1076~1084 (2006)
23. Bernardo ME, "Mesenchymal stromal cells", Ann N Y Acad Sci, 1176, pp.101~117 (2009)
24. Vemuri MC, "Mesenchymal stem cell assays and applications", Methods Mol Biol, 698, pp.3~8 (2011)
25. Keum Seok Bae, "Neuron-Like Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells", Yonsei Medical Journal, 52(3), pp.401~412 (2011), 연세대학교의과대학
26. Horwitz EM, "Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement", Cytotherapy, 7, pp.393~395 (2005)
27. Bianco P, "Postnatal skeletal stem cells", Methods Enzymol, 419, pp.117~148 (2006)
28. Laflamme MA, "Regenerating the heart", Nat Biotechnol, 23, pp.845~856 (2005)
29. Chen J, "Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat", J Neurosci Res, 73, pp.778~786 (2003)
30. Li Y, "Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells", Glia, 49, pp.407~417 (2005)
31. Murphy JM, "Stem cell therapy in a caprine model of osteoarthritis", Arthritis Rheum, 48, pp.3464~3474 (2003)
32. Rosová I, "Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells", Stem Cells, 26, pp.2173~2182 (2008)
33. Nagai A, "Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow", PLoS One, 2, pp.1272~ (2007)
34. Li Y, "Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery", Neurology, 59, pp.514~523 (2002)
35. Qu R, "Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts", Neuropathology, 27, pp.355~363 (2007)
36. Cho SR, "Neurally induced umbilical cord blood cells modestly repair injured spinal cords", Neuroreport, 19, pp.1259~1263
37. Yoo SW, "Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model", Experimental and Molecular Medicine, 40(4), pp.387~397 (2008), 생화학분자생물학회
38. Kopen GC, "Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains", Proc Natl Acad Sci U S A, 96, pp.10711~10716 (1999)
39. Kim SS, "Neural induction with Neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain", STEM CELLS, 26, pp.2217~2228, ALPHAMED PRESS
40. Maltman DJ, "Role of mesenchymal stem cells in neurogenesis and nervous system repair", Neurochem Int, 59, pp.347~356 (2011)
41. Sakai T, "Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis", Nat Med, 7, pp.324~330 (2001)
42. Giger RJ, "Guidance molecules in axon regeneration", Cold Spring Harb Perspect Biol, 2, pp.a001867~ (2010)
43. Akiyama Y, "Remyelination of the spinal cord following intravenous delivery of bone marrow cells", Glia, 39, pp.229~236 (2002)
44. Satake K, "Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue", Spine, 29, pp.1971~1979 (2004)
45. Uccelli A, "Mesenchymal stem cells in health and disease", Nat Rev Immunol, 8, pp.726~736 (2008)
46. Zappia E, "Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy", Blood, 106, pp.1755~1761 (2005)
47. Gerdoni E, "Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis", Ann Neurol, 61, pp.219~227 (2007)
48. Kim YJ, "Neuroprotective Effects of Human Mesenchymal Stem Cells on Dopaminergic Neurons Through Anti-Inflammatory Action", GLIA, 57(1), pp.13~23, WILEY-LISS
49. Chao YX, "Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson’s disease", J Neuroimmunol, 216, pp.39~50 (2009)
50. Ohtaki H, "Stem", progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory, Proc Natl Acad Sci U S A, pp.2008, 105[DOI]
51. Seo JH, "Immunomodulation from intravenous transplantation of mesenchymal stem cells promotes functional recovery in spinal cord injured rats", Cell Med, 2, pp.55~67 (2011)
52. Gnecchi M, "Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement", FASEB J, 20, pp.661~669 (2006)
53. Cai L, "Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization", Stem Cells, 25, pp.3234~3243 (2007)
54. Nakagami H, "Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells", Arterioscler Thromb Vasc Biol, 25, pp.2542~2547 (2005)
55. Rehman J, "Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells", Circulation, 109, pp.1292~1298 (2004)
56. Sadat S, "The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF", Biochem Biophys Res Commun, 363, pp.674~679 (2007)
57. Miranville A, "Improvement of postnatal neovascularization by human adipose tissue-derived stem cells", Circulation, 110, pp.349~355 (2004)
58. Crigler L, "Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis", Exp Neurol, 198, pp.54~64 (2006)
59. Cho SR, "Functional recovery after the transplantation of neurally differentiated mesenchymal stem cells derived from bone barrow in a rat model of spinal cord injury", Cell Transplant, 18, pp.1359~1368 (2009)
60. Cho HJ, "Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart", J Exp Med, 204, pp.3257~3269 (2007)
61. Tateno K, "Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization", Circ Res, 98, pp.1194~1202 (2006)
62. Si YL, "MSCs: biological characteristics, clinical applications and their outstanding concerns", Ageing Res Rev, 10, pp.93~103 (2011)
63. Koc ON, "Mesenchymal stem cells: heading into the clinic", Bone Marrow Transplant, 27, pp.235~239 (2001)
64. Horwitz EM, "Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone", Proc Natl Acad Sci U S A, 99, pp.8932~8937 (2002)
65. Dimmeler S, "Unchain my heart: the scientific foundations of cardiac repair", J Clin Invest, 115, pp.572~583 (2005)
66. Loebinger MR, "Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer", Cancer Res, 69, pp.4134~4142 (2009)
67. Aguayo-Mazzucato C, "Stem cell therapy for type 1 diabetes mellitus", Nat Rev Endocrinol, 6, pp.139~148 (2010)
68. Pistoia V, "Potential of mesenchymal stem cells for the therapy of autoimmune diseases", Expert Rev Clin Immunol, 6, pp.211~218 (2010)
69. Minger SL, "Endogenous neurogenesis in the human brain following cerebral infarction", Regen Med, 2, pp.69~74 (2007)
70. Ekonomou A, "Increased neural progenitors in vascular dementia", Neurobiol Aging, 32, pp.2152~2161 (2011)
71. Bang OY, "Autologous mesenchymal stem cell transplantation in stroke patients", Ann Neurol, 57, pp.874~882 (2005)
72. Lee JS, "STARTING collaborators. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke", Stem Cells, 28, pp.1099~1106 (2010)
73. Zhang ZX, "A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury", Cytotherapy, 10, pp.134~139 (2008)
74. Joyce N, "Mesenchymal stem cells for the treatment of neurodegenerative disease", Regen Med, 5, pp.933~946 (2010)
75. Schwab ME, "Repairing the injured spinal cord", Science, 295, pp.1029~1031 (2002)
76. Sahni V, "Stem cell therapies for spinal cord injury", Nat Rev Neurol, 6, pp.363~372 (2010)
77. Geffner LF, "Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies", Cell Transplant, 17, pp.1277~1293 (2008)
78. Syková E, "Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury", Cell Transplant, 15, pp.675~687 (2006)
79. Pal R, "Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury", paraplegia: a pilot clinical study, 2009, pp.11, 897~911
80. Ra JC, "Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans", Stem Cells Dev, 20, pp.1297~1308 (2011)
81. Li JY, "Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation", Nat Med, 14, pp.501~503 (2008)
82. Venkataramana NK, "Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson’s disease", Transl Res, 155, pp.62~70 (2010)
83. Lee PH, "Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy", Clin Pharmacol Ther, 83, pp.723~730 (2008)
84. Nagano I, "Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis", Neurol Res, 27, pp.768~772 (2005)
85. Karussis D, "Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis", Arch Neurol, 67, pp.1187~1194 (2010)
86. Mazzini L, "Stem cell treatment in Amyotrophic Lateral Sclerosis", J Neurol Sci, 265, pp.78~83 (2008)
87. Mazzini L, "Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial", Exp Neurol, 223, pp.229~237 (2010)
88. Mohyeddin Bonab M, "Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study", Iran J Immunol, 4, pp.50~57 (2007)
89. Yamout B, "Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study", J Neuroimmunol, 227, pp.185~189 (2010)

관련 논문AI추천